2nd Annual NDDS India 2011 (NDDS India 2011)
|Event Date/Time: Aug 10, 2011||End Date/Time: Aug 12, 2011|
|Early Registration Date: May 13, 2011|
fraction of this at INR 1000 crore, there are a host of opportunities for development and commercialisation of NDDS
products to be capitalised upon.
But are you fully prepared to meet global regulatory standards, to innovate and take the first-mover advantage, to scale-up
whilst maintaining QbD, and to enter new markets whilst retaining leadership in existing markets?
Attend NDDS India 2011 to gather all the business-critical information you need to meet the above challenges. Gain
practical and implementable guidance on the latest regulatory requirements, formulation and design solutions, therapeutic
applications, and commercialisation strategies specific to NDDS products developed in Indian markets.
Over the two information-packed days you will benefit from:
â€¢ Key national and international regulatory bodies providing clarification around guidelines for quality NDDS
â€¢ Visionary decision-makers from leading international and domestic pharmaceutical companies sharing
their practical experiences of how NDDS development can complement long-term growth plans
â€¢ Leading scientists from industry and academic institutions discussing solutions to the formulation and design
challenges faced when scaling-up production to make NDDS products commercially viable
â€¢ Principal strategy planners presenting implementable ways to capitalise on the opportunities available for
NDDS products in existing and new markets
Just some of the expert speakers who have confirmed their presence at this early stage include:
â€¢ Sumedh Gaikwad, Director, Medical Services, Richter Themis Medicare
â€¢ Mahesh V Chaubal, Director Product Development, Baxter Healthcare, USA
â€¢ Kapileshwar Swain, Vice President Product Development, Macleods Pharma
â€¢ Damon Smith, Senior Vice President Research and Development, Labopharm, USA
â€¢ SP Vyas, Professor, Department of Pharmaceutical Sciences, Sagar University, India
â€¢ Dhiraj Khattar, Director Formulations, Fresenius Kabi Oncology
â€¢ Devaraj Rambhau, Advisor NDDS, Natco Research Centre
â€¢ Subhash C Mandal, Senior Drug Inspector, Directorate of Dru gs Control, West Bengal, Kolkata
Plus many othersâ€¦
Donâ€™t delay! Please call us today on +91 (022) 4046 1466 or email us at email@example.com
We look forward to welcoming you to the event in August.